- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/18 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
Patent holdings for IPC class C07D 295/18
Total number of patents in this class: 106
10-year publication summary
|
1
|
0
|
3
|
3
|
0
|
0
|
0
|
1
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| AstraZeneca AB | 2814 |
4 |
| Boehringer Ingelheim International GmbH | 4493 |
4 |
| Ajinomoto Co., Inc. | 2277 |
4 |
| Astellas Pharma Inc. | 1044 |
4 |
| Bristol-myers Squibb Company | 4742 |
3 |
| AstraZeneca UK Limited | 528 |
3 |
| JSR Corporation | 2554 |
3 |
| Takeda Pharmaceutical Company Limited | 2712 |
3 |
| Allergan, Inc. | 2167 |
2 |
| Konica Minolta, Inc. | 9119 |
2 |
| Dai Nippon Printing Co., Ltd. | 4238 |
2 |
| Arbor Pharmaceuticals, LLC | 64 |
2 |
| Daicel Corporation | 2523 |
2 |
| Kyoto University | 2904 |
2 |
| Nagoya Industrial Science Research Institute | 18 |
2 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 130 |
2 |
| XenoPort, Inc. | 75 |
2 |
| PFG Holding Corporation | 117 |
2 |
| Merck Sharp & Dohme LLC | 3734 |
2 |
| Vantage Biosciences Ltd. | 3 |
2 |
| Other owners | 54 |